Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

Share Price is delayed by 15 minutes
Get Live Data
2.10    0.03 (1.45%)
Bid:
2.01
Ask:
2.10
Spread: 0.09 (4.478%)
Market Cap: £2.17m
LIT Live PriceLast checked at - London Stock Exchange

Intraday Litigation Cap. Share Chart

Settlement of litigation project

21 Dec 2018 07:01

RNS Number : 1812L
Litigation Capital Management Ltd
21 December 2018
 

21 December 2018

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

Settlement of litigation project

 

Litigation Capital Management Limited (AIM:LIT), a leading international provider of litigation financing solutions, today announces that a settlement has been reached in respect of one of its litigation projects.

 

Highlights

§ Expected to contribute over A$1.5 million in revenue for the current financial year to 30 June 2019; with a similar sized contribution to EBITDA

§ The litigation project was managed to settlement in less than one month

§ Third litigation project that LCM has completed in the current financial year

 

The parties involved in the litigation project are undisclosed, but it relates to an international arbitration case. International arbitration represents one of several types of litigation projects that LCM provides funding for across single-case and portfolio funding, as well as class actions, commercial claims and claims arising out of insolvency.

 

LCM has also entered into an agreement to provide litigation finance in relation to proceedings brought in the Supreme Court of Western Australia. The terms of the funding agreement are subject to confidentiality between the parties involved and are therefore undisclosed.

 

Patrick Moloney, CEO of LCM, said: 

"The ability of LCM to manage this litigation project to completion in such a short time period is reflective of LCM's active project management approach in an opportunistic situation and we will look to replicate this where we can. Across the diverse portfolio of litigation projects we finance, international arbitration is one of a number of sectors in which we expect to see continued growth in the coming years, particularly in markets such as Hong Kong and Singapore." 

 

-ENDS-

 

CONTACTS

 

Litigation Capital Management

Patrick Moloney, Chief Executive Officer

Nick Rowles-Davies, Executive Director

 

Canaccord (Nomad and Broker) Tel: 020 7523 8000

Sunil Duggal / Emma Gabriel / Michael Reynolds

 

Hawthorn Advisors lcm@hawthornadvisors.com

Lorna Cobbett / Zinka MacHale Tel: 020 3745 4960

 

 

 

 

 

NOTES TO EDITORS

 

About LCM

Litigation Capital Management ("LCM") is a leading international provider of litigation financing solutions. This includes single-case and portfolio; across class actions, commercial claims, claims arising out of insolvency and international arbitration. LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management. Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM has been listed on AIM since December 2018, trading under the ticker LIT. www.lcmfinance.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFKKDDABDDKBB
Date   Source Headline
1st Jun 20267:00 amRNSUpdate on Covenant Waiver, Case & Strategic Review
15th Apr 20267:30 amRNSCovenant Waiver Extension
31st Mar 20267:00 amRNSInterim results for the HY ended 31 December 2025
25th Mar 20267:00 amRNSNotice of H1 Results, Trading update and IMC
17th Mar 20267:00 amRNSJudgment Delivered in Commercial Litigation Claim
17th Mar 20267:00 amRNSJudgment Delivered in Commercial Litigation Claim
11th Mar 20269:34 amRNSUpdate on Case Investment and Strategic Review
2nd Mar 20267:00 amRNSCovenant Waiver Extension
2nd Feb 20267:00 amRNSIncrease in Credit Facility and Waiver Extension
12th Jan 20262:07 pmRNSPositive development on case
30th Dec 20257:00 amRNSCovenant Waiver Extension
30th Dec 20257:00 amRNSCovenant Waiver Extension
24th Dec 20257:00 amRNSAdverse Costs Order in Class Action Investment
27th Nov 20251:08 pmRNSResults of AGM
26th Nov 20255:00 pmRNSStrategic Review Update
19th Nov 202511:54 amRNSPosting of Annual Report and Accounts
4th Nov 20252:29 pmRNSNotice of Annual General Meeting
21st Oct 202511:37 amRNSPostponement of Annual General Meeting
13th Oct 202511:39 amRNSExercise of Awards
6th Oct 20257:00 amRNSUpdate on Commercial Arbitration Loss
2nd Oct 20258:40 amRNSTR-1
1st Oct 20254:49 pmRNSNotice of Annual General Meeting
1st Oct 202511:25 amRNSJudgment Delivered in Commercial Litigation Claim
1st Oct 20257:00 amRNSAnnual Results for the year ended 30 June 2025
15th Sep 20257:00 amRNSClass Action Investment and Strategic Review
8th Sep 20257:00 amRNSNotice of Results
23rd Jun 20259:45 amRNSTR - 1
19th Jun 20257:00 amRNSJudgment in Funded Case and Trading Update
13th May 20252:50 pmRNSStatement Regarding Media Speculation
1st Apr 20257:00 amRNSOutcome of Commercial Arbitration Investment
18th Mar 20257:00 amRNSInterim results for the HY ended 31 December 2024
7th Mar 20252:54 pmRNS-RInvestor Presentation via Investor Meet Company
28th Feb 20257:00 amRNSAppeal Filed in Class Action Investment
21st Feb 20257:00 amRNSJudgment Delivered in Class Action Investment
4th Feb 20258:33 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSTrading Update
15th Jan 202511:14 amRNSHolding(s) in Company
19th Dec 20247:00 amRNSDirectorate Change
6th Dec 202411:15 amRNSHolding(s) in Company
6th Dec 20247:00 amRNSAppointment of CFO to the Board of Directors
4th Dec 20247:00 amRNSJudgment Delivered in Class Action Investment
2nd Dec 20247:00 amRNSNew Credit Facility
15th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20247:06 amRNSHolding(s) in Company
8th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.